Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment

被引：205

作者：

Oeckl, Patrick ^{[1
]}

Halbgebauer, Steffen ^{[1
]}

Anderl-Straub, Sarah ^{[1
]}

Steinacker, Petra ^{[1
]}

Huss, Andre M. ^{[1
]}

Neugebauer, Hermann ^{[1
]}

von Arnim, Christine A. F. ^{[1
]}

Diehl-Schmid, Janine ^{[2
]}

Grimmer, Timo ^{[2
]}

Kornhuber, Johannes ^{[3
,4
]}

Lewczuk, Piotr ^{[3
,4
,5
]}

Danek, Adrian ^{[6
]}

Ludolph, Albert C. ^{[1
]}

Otto, Markus ^{[1
]}

机构：

[1] Ulm Univ Hosp, Dept Neurol, Oberer Eselsberg 45, D-89081 Ulm, Germany

[2] Tech Univ Munich, Dept Psychiat & Psychotherapy, Klinikum Rechts Isar, Munich, Germany

[3] Univ Klinikum Erlangen, Dept Psychiat & Psychotherapy, Erlangen, Germany

[4] Friedrich Alexander Univ Erlangen Nuremberg, Erlangen, Germany

[5] Med Univ Bialystok, Dept Neurodegenerat Diagnost, Bialystok, Poland

[6] Ludwig Maximilians Univ Munchen, Dept Neurol, Univ Hosp, Munich, Germany

[7] Univ Ulm, German Consortium Frontotemporal Lobar Degenerat, Ulm, Germany

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2019年 / 67卷 / 02期

关键词：

Alzheimer's disease; astrocyte; biomarker; cerebrospinal fluid; differential diagnosis; frontotemporal dementia; GFAP; Lewy body dementia; Parkinson's disease; serum; NEUROFILAMENT LIGHT-CHAIN; CEREBROSPINAL-FLUID; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; PLASMA; DEMENTIA; RECOMMENDATIONS; CRITERIA; LEVEL;

D O I：

10.3233/JAD-180325

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Reliable blood biomarkers for Alzheimer's disease (AD) are missing. We measured astroglial GFAP in patients with AD (n = 28), frontotemporal dementia (bvFTD, n = 35), Parkinson's disease (n = 11), Lewy body dementias (n = 19), and controls (n = 34). Serum GFAP was increased in AD (p < 0.001) and DLB/PDD (p < 0.01), and cerebrospinal fluid GFAP was increased in all neurodegenerative diseases (p < 0.001). Serum GFAP correlated with the Mini-Mental State Examination score (r = -0.42, p < 0.001) and might be a follow-up marker in clinical trials. Sensitivity and specificity of serum GFAP for AD versus bvFTD was 89% and 79% and might be the first blood biomarker in the differential diagnosis of AD and bvFTD.

引用

页码：481 / 488

页数：8

共 50 条

[21] Serum Glial Fibrillary Acidic Protein in Acute Stroke
Seder, David B.
NEUROCRITICAL CARE, 2020, 33 (01) : 35 - 36
[22] Serum Glial Fibrillary Acidic Protein in Acute Stroke
David B. Seder
Neurocritical Care, 2020, 33 : 35 - 36
[23] Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology
Shir, Dror
Graff-Radford, Jonathan
Hofrenning, Ekaterina I. I.
Lesnick, Timothy G. G.
Przybelski, Scott A. A.
Lowe, Val J. J.
Knopman, David S. S.
Petersen, Ronald C. C.
Jack, Clifford R. R.
Vemuri, Prashanthi
Algeciras-Schimnich, Alicia
Campbell, Michelle R. R.
Stricker, Nikki H. H.
Mielke, Michelle M. M.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2022, 14 (01)
[24] Serum Glial Fibrillary Acidic Protein: A Biomarker of Disease Progression in Multiple Sclerosis
Barro, C.
Healy, B.
Liu, Y.
Saxena, S.
Paul, A.
Polgar-Turcsanyi, M.
Guttmann, C.
Bakshi, R.
Kropshofer, H.
Weiner, H.
Chitnis, T.
EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 154 - 154
[25] Serum neurofilament light chain but not serum glial fibrillary acidic protein is a marker of early Huntington's disease
Heim, Beatrice
Mandler, Elias
Peball, Marina
Carbone, Federico
Schwarzova, Katarina
Demjaha, Rina
Tafrali, Cansu
Buchmann, Arabella
Khalil, Michael
Djamshidian, Atbin
Seppi, Klaus
JOURNAL OF NEUROLOGY, 2025, 272 (02)
[26] Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis
Madill, Evan
Healy, Brian C.
Molazadeh, Negar
Polgar-Turcsanyi, Mariann
Glanz, Bonnie I.
Weiner, Howard L.
Chitnis, Tanuja
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (10): : 2719 - 2730
[27] THE GLIAL FIBRILLARY ACIDIC PROTEIN
JACQUE, CM
PRESSE MEDICALE, 1991, 20 (29): : 1384 - 1390
[28] Serum glial fibrillary acidic protein indicates memory impairment in patients with chronic heart failure
Traub, Jan
Otto, Markus
Sell, Roxane
Homola, Gyoergy A.
Steinacker, Petra
Oeckl, Patrick
Morbach, Caroline
Frantz, Stefan
Pham, Mirko
Stoerk, Stefan
Stoll, Guido
Frey, Anna
ESC HEART FAILURE, 2022, 9 (04): : 2626 - 2634
[29] GLIAL FIBRILLARY ACIDIC PROTEIN AND ALZHEIMERS-DISEASE
PANTER, SS
MCSWIGAN, JD
SHEPPARD, JR
EMORY, CR
FREY, WH
NEUROCHEMICAL RESEARCH, 1985, 10 (12) : 1567 - 1576
[30] Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
Pratishtha Chatterjee
Steve Pedrini
Erik Stoops
Kathryn Goozee
Victor L. Villemagne
Prita R. Asih
Inge M. W. Verberk
Preeti Dave
Kevin Taddei
Hamid R. Sohrabi
Henrik Zetterberg
Kaj Blennow
Charlotte E. Teunissen
Hugo M. Vanderstichele
Ralph N. Martins
Translational Psychiatry, 11

← 1 2 3 4 5 →